Nitrobenzofuroxane derivatives as dual action HIV-1 inhibitors

Nitrobenzofuroxane derivatives as dual action HIV-1 inhibitors Full article

Journal

Биомедицинская химия
ISSN: 2310-6905 , E-ISSN: 2310-6972

Output data

Year: 2016, Volume: 62, Number: 6, Pages: 725-728 Pages count : 4 DOI: 10.18097/pbmc20166206725

Authors

Korolev S.P. ¹ , Pustovarova M.A. ¹ , Starosotnikov A.M. ² , Bastrakov M.A. ² , Agapkina Yu.Yu. ¹ , Shevelev S.A. ² , Gottikh M.B. ¹

Affiliations

1	Belozeksky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia
2	Zelinsky Institute of Organic Chemistry, Moscow, Russia

Human immunodeficiency virus first type (HIV-1) is a main cause of one of the most dangerous diseases, AIDS. The search for new inhibitors of the virus still remains an urgent task. One approach to suppress the HIV infection is to use a double-acting inhibitors, i.e. inhibitors directed to two stages of the viral life cycle. The catalytic domain of HIV-1 integrase has a similar spatial organization with ribonuclease (RNase H) domain of HIV-1 reverse transcriptase, and approach aimed to create HIV-1 integrase and RNase H double-acting is very promising. In this work we synthesized a series of 6-nitrobenzofuroxane derivatives and studied their ability to inhibit two viral enzymes – integrase and RNase H HIV-1.

Korolev S.P. , Pustovarova M.A. , Starosotnikov A.M. , Bastrakov M.A. , Agapkina Y.Y. , Shevelev S.A. , Gottikh M.B.
Nitrobenzofuroxane derivatives as dual action HIV-1 inhibitors
Биомедицинская химия. 2016. V.62. N6. P.725-728. DOI: 10.18097/pbmc20166206725 Scopus OpenAlex

Scopus:	2-s2.0-85016122975
OpenAlex:	W2747277708

DB	Citing
OpenAlex	3
Scopus	3